|
Galectin Therapeutics
sst2 Sst2, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/pmc13260791-36-16-17 Average 86 stars, based on 1 article reviews
sst2 - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
soluble st2 sst2 Soluble St2 Sst2, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/pm42265793-163-4-8 Average 86 stars, based on 1 article reviews
soluble st2 sst2 - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
bnp ntprobnp • hs ctnt • sst2 • galectin Bnp Ntprobnp • Hs Ctnt • Sst2 • Galectin, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/pm42251458-185-3-10 Average 86 stars, based on 1 article reviews
bnp ntprobnp • hs ctnt • sst2 • galectin - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
Elabscience Biotechnology
soluble st2 sst2 Soluble St2 Sst2, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/Human+sST2+(Soluble+ST2)+ELISA+Kit/10__26505_slash_djm__v30i1__1333-55-12-22 Average 94 stars, based on 1 article reviews
soluble st2 sst2 - by Bioz Stars,
2026-10
94/100 stars
|
Buy from Supplier |
|
Galectin Therapeutics
tumorigenicity 2 sst2 Tumorigenicity 2 Sst2, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/pm41900919-34-10-13 Average 86 stars, based on 1 article reviews
tumorigenicity 2 sst2 - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
R&D Systems
sst2 dst200 ![]() Sst2 Dst200, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sst2/Human+ST2%2FIL-33R+Quantikine+ELISA+Kit/pmc13094069-69-6-14 Average 95 stars, based on 1 article reviews
sst2 dst200 - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
Journal: Molecular Medicine
Article Title: Dual and context-dependent role of the interleukin-33/soluble suppression of tumorigenicity 2 axis in obesity and adipose tissue inflammation
doi: 10.1186/s10020-026-01454-z
Figure Lengend Snippet: Effect of obesity and sex on the circulating levels of interleukin (IL)-33 and soluble suppression of tumorigenicity 2 (sST2). Fasting serum concentrations of ( A ) IL-33, ( C ) sST2 and ( E ) IL-33/sST2 in normal-weight (NW-NG) volunteers ( n = 22), patients with obesity with normoglycemia (OB-NG) ( n = 24) and with obesity-associated type 2 diabetes (OB-T2D) ( n = 27). Circulating concentrations of ( B ) IL-33, ( D ) sST2 and ( F ) IL-33/sST2 in males ( n = 26) and females ( n = 47) volunteers. Data are mean ± SEM. Differences between groups were analyzed by one-way ANOVA followed by Tukey’s tests or by unpaired two-tailed Student’s t test as appropriate. * P < 0.05, ** P < 0.01 and *** P < 0.001
Article Snippet: Circulating concentrations of IL-33 (D3300B) and
Techniques: Two Tailed Test
Journal: Molecular Medicine
Article Title: Dual and context-dependent role of the interleukin-33/soluble suppression of tumorigenicity 2 axis in obesity and adipose tissue inflammation
doi: 10.1186/s10020-026-01454-z
Figure Lengend Snippet: The increased circulating levels of IL-33 in obesity together the decrease in its soluble decoy receptor sST2 may be potentially enhancing IL-33 bioactivity. In addition, gene and protein expression levels of IL-33 in visceral adipose tissue (VAT) are upregulated in obesity in both adipocytes and stromal vascular fraction cells. IL-33 modulates adipocyte function by upregulating both anti-inflammatory mediators ( ADIPOQ , ITLN1 and IL13 ) and pro-inflammatory cytokines ( TNF , IL8 ). Under inflammatory conditions, such as LPS stimulation, IL-33 attenuates excessive pro-inflammatory responses and promotes protective adipokine expression in visceral adipocytes. In THP-1-derived macrophages, adipocyte-derived factors suppress IL33 expression, whereas IL-33 attenuates macrophage pro-inflammatory activation and enhances IL4 expression only in the context of adipocyte-conditioned medium. Together, these findings suggest the dual and context-dependent nature of IL-33 in obesity, acting as a compensatory mediator to maintain tissue homeostasis while potentially contributing to chronic low-grade inflammation when elevated chronically. ADIPOQ, adiponectin; IL , interleukin; ITLN1 , omentin; TNF , tumor necrosis factor α
Article Snippet: Circulating concentrations of IL-33 (D3300B) and
Techniques: Expressing, Derivative Assay, Activation Assay